{"title":"Antibacterial Activity of a Novel Depsipeptide and Prodigiosine of Serratia marcescans S823","authors":"Linyan Zhu, Cuiping Pang, Liqun Chen, Xiangdong Zhu","doi":"10.4172/2329-6836.1000312","DOIUrl":null,"url":null,"abstract":"To investigate the antimicrobial activity of secondary metabolites from Serratia marcescans S823. The strain Serratia marcescans S823 was screened for its antibacterial activity. The active components from the bacterium were isolated by bioactivity-guided analysis. Their structures were identified by chemical and spectroscopic methods to be prodigiosine (PG) (1), serratamolide A (2) and serratamolide G (3), which is a new compound. The MIC and MBC of prodigiosine and serratamolide G were 6.25 μg.mL-1 and 12.5 μg.mL-1 against C. albicans and 6.25 μg.mL-1 and 25 μg.mL-1 against B. thuringiensis respectively. They might be potential alternative treatment options for Candida albicans infection. This study encourages further investigation of natural products as new antibiotics.","PeriodicalId":18897,"journal":{"name":"Natural products chemistry & research","volume":"55 1","pages":"1-7"},"PeriodicalIF":0.0000,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Natural products chemistry & research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2329-6836.1000312","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5
Abstract
To investigate the antimicrobial activity of secondary metabolites from Serratia marcescans S823. The strain Serratia marcescans S823 was screened for its antibacterial activity. The active components from the bacterium were isolated by bioactivity-guided analysis. Their structures were identified by chemical and spectroscopic methods to be prodigiosine (PG) (1), serratamolide A (2) and serratamolide G (3), which is a new compound. The MIC and MBC of prodigiosine and serratamolide G were 6.25 μg.mL-1 and 12.5 μg.mL-1 against C. albicans and 6.25 μg.mL-1 and 25 μg.mL-1 against B. thuringiensis respectively. They might be potential alternative treatment options for Candida albicans infection. This study encourages further investigation of natural products as new antibiotics.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
